These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27787887)

  • 1. A randomized, split-face, controlled, double-blind, single-centre clinical study: transient addition of a topical corticosteroid to a topical retinoid in patients with acne to reduce initial irritation.
    Coman GC; Holliday AC; Mazloom SE; Chavan RN; Kolodney MS
    Br J Dermatol; 2017 Aug; 177(2):567-569. PubMed ID: 27787887
    [No Abstract]   [Full Text] [Related]  

  • 2. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
    Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
    Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
    Leyden JJ; Tanghetti EA; Miller B; Ung M; Berson D; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):12-9. PubMed ID: 12095064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short contact therapy of acne with tretinoin.
    Veraldi S; Barbareschi M; Benardon S; Schianchi R
    J Dermatolog Treat; 2013 Oct; 24(5):374-6. PubMed ID: 23167277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-Blind, Split-Face Study to Compare the Irritation Potential of Two Topical Acne Formulations Over a 21-Day Treatment Period.
    Kircik LH; Bhatt V; Martin G; Pillai R
    J Drugs Dermatol; 2016 Feb; 15(2):178-82. PubMed ID: 26885785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black population.
    Bhatia ND; Werschler WP; Cook-Bolden FE; Guenin E
    Cutis; 2020 Jul; 106(1):45-50;E1. PubMed ID: 32915939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
    Jarratt MT; Brundage T
    J Drugs Dermatol; 2012 Mar; 11(3):318-26. PubMed ID: 22395582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Randomized, Double-Blind, Split-Face Studies to Compare the Irritation Potential of Two Topical Acne Fixed Combinations Over a 21-Day Treatment Period.
    Bhatia N; Bhatt V; Martin G; Pillai R
    J Drugs Dermatol; 2016 Jun; 15(6):721-6. PubMed ID: 27272079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.
    Shemer A; Shiri J; Mashiah J; Farhi R; Gupta AK
    J Am Acad Dermatol; 2016 Jun; 74(6):1251-2. PubMed ID: 27185426
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
    Tirado-Sánchez A; Espíndola YS; Ponce-Olivera RM; Bonifaz A
    J Cosmet Dermatol; 2013 Jun; 12(2):103-7. PubMed ID: 23725303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of plane warts by tretinoin-induced irritant reaction.
    al Aboosi M
    Int J Dermatol; 1994 Nov; 33(11):826-7. PubMed ID: 7822092
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Sheehan-Dare R; Layton A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative and quantitative assessment of the application and use of topical acne medication by patients.
    Del Rosso JQ
    Cutis; 2005 Aug; 76(2):109-13. PubMed ID: 16209156
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind investigation of the potential systemic absorption of isotretinoin, when combined with chemical sunscreens, following topical application to patients with widespread acne of the face and trunk.
    Cunliffe WJ; Glass D; Goode K; Stables GI; Boorman GC
    Acta Derm Venereol; 2001; 81(1):14-7. PubMed ID: 11411906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
    Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
    J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.